Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of remimazolam in liver and renal transplant patients after continuous infusion
ChiCTR2200065454Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in postoperative sedation (3 arms), sponsored by Renji Hospital. Primary endpoint: Plasma concentration of remimazolam and metabolites. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative sedation
Beyond the preview
Go deeper on ChiCTR2200065454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065454.